Our Latest
News & Blog
Follow the progress of Predicta Biosciences through company announcements, funding milestones, product launches, scientific discoveries, and industry insights focused on transforming the diagnosis and treatment of complex diseases.
News
News
Predicta Biosciences and CIMA LAB Diagnostics Announce Agreement to Advance Ultrasensitive Blood-Based Diagnostics for Multiple Myeloma and Other Hematological Malignancies
News
Predicta Biosciences Appoints Dr. Craig L. Tendler as Independent Director to its Board
News
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
News
Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases
News
Predicta Biosciences Launches its First Molecular Diagnostic Product to Improve the Prognosis of Multiple Myeloma
News
This Startup Raised $5.2 Million To Develop Blood Tests For Cancer
News
Predicta Biosciences Secures $5.2M to Transform the Diagnosis, Treatment and Monitoring of Blood Cancers
Predicta Newsletter
Enter your email address to subscribe.
Enter Email Address:
Predicta Biosciences
750 Main Street, Lab 413
Cambridge, MA 02139